Results 141 to 150 of about 37,378 (259)

Assessment of the pesticide active substance carvone (d‐/l‐carvone at a ratio of at least 100:1) for inclusion in Annex IV of Regulation (EC) No 396/2005

open access: yesEFSA Journal, 2016
According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) was required to review the maximum residue levels (MRLs) currently established at European level for the pesticide active substance carvone (d‐/l‐carvone at
European Food Safety Authority (EFSA)
doaj   +1 more source

Missense Variants in the Second Transmembrane Domain of TMEM17 Disrupt Its Stability and Function and Lead to a Wide Phenotypic Spectrum of Ciliopathies

open access: yesClinical Genetics, Volume 109, Issue 2, Page 305-315, February 2026.
Missense variants in TMEM17 disrupt its localization and function at the ciliary transition zone, leading to a wide range of ciliopathy phenotypes, from OFD6 and Joubert syndromes to Meckel syndrome. ABSTRACT Ciliopathies are rare genetic disorders characterized by significant genetic and phenotypic variability.
Lucile Boutaud   +19 more
wiley   +1 more source

Vulnerability of marine megafauna to global at‐sea anthropogenic threats

open access: yesConservation Biology, Volume 40, Issue 1, February 2026.
Abstract Marine megafauna species are affected by a wide range of anthropogenic threats. To evaluate the risk of such threats, species’ vulnerability to each threat must first be determined. We build on the existing threats classification scheme and ranking system of the International Union for Conservation of Nature (IUCN) Red List of Threatened ...
Michelle VanCompernolle   +309 more
wiley   +1 more source

Evaluation of hybrid DIR performance using controlling structures and points of interest in MR‐guided adaptive radiotherapy for prostate cancer patients

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background MR‐guided adaptive radiotherapy (ART) allows for daily plan optimization based on patient‐specific anatomy. Accumulated doses, driven by deformable image registration (DIR), of daily fractions can provide cumulative dose metrics and insights into toxicity and tumor control.
Victor Malkov   +10 more
wiley   +1 more source

Control‐point‐specific plan robustness in volumetric modulated arc therapy‐based cranial radiotherapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background Progress in mitigating plan degradation due to intrafraction patient motion may involve the identification and management of specific control points that are sensitive to motion. Robust planning in this manner could improve deliverable dosimetry and support advancements toward reducing planning target volume (PTV) margins.
Daniel Crawford   +2 more
wiley   +1 more source

Quality of Organic vs. Conventional Food and Effects on Health [PDF]

open access: yes, 2011
This report analyses the nutritional quality of organic and conventional food as well as the health effects of pesticide residues, nitrates, mycotoxins and artificial additives and gives an overview of animal and human ...
Luik, Anne   +4 more
core  

Cell Surface Thiol Engineering Mechanoregulates Myogenic Differentiation via the FAK–PI3K–AKT Axis

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 2, 14 January 2026.
Schematic diagram illustrating how cell surface modification of skeletal muscle progenitor cells through TCEP treatment reveals enhanced cell adhesion, intracellular tension, and myogenesis at 19.66 kPa stiffness, leading to optimal cell fusion. In contrast, no significant changes are observed in the softer (10.61 kPa) or stiffer (49.4 kPa) matrices ...
Juyeon Kim   +10 more
wiley   +1 more source

Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for penconazole in various crops. [PDF]

open access: yesEFSA J, 2023
European Food Safety Authority (EFSA)   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy